Trademark: 97347411
Word

Status
Pending
Status Code
616
Status Date
Thursday, February 22, 2024
Serial Number
97347411
Mark Type
2000
Filing Date
Tuesday, April 5, 2022
Published for Opposition
Tuesday, November 15, 2022

Trademark Owner History
JN BIDCO LLC - 1st New Owner After Publication
IMPEL PHARMACEUTICALS INC. - Owner At Publication
Impel NeuroPharma, Inc. - Original Applicant

Classifications
5 Pharmaceutical preparations for the treatment and alleviation of disorders of the central nervous system; Pharmaceutical preparations for the treatment and alleviation of migraine headaches; Pharmaceutical preparations for the treatment and alleviation of agitation and aggression; Pharmaceutical preparations for the treatment and alleviation of Parkinson's disease
35 Providing information regarding patient assistance programs, namely, discount programs for enabling participants to obtain discounts on prescription drugs through enrollment with participating pharmacies
44 Providing information regarding patient assistance programs, namely, information relating to diagnostic and therapeutic properties of pharmaceuticals and dispensing pharmaceuticals and medical treatment
10 Drug delivery systems, namely, inhalers for medical use; dosing aids and apparatus for medicines, namely, drug delivery and dispensing devices and systems being inhalers for medical use; nasal, respiratory, and sinus drug delivery devices and parts therefor, namely, inhalers for medical use
42 Biomedical research services; Research and development of new products for medicinal use for others; Development and testing of pharmaceutical products and drug delivery technology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development; Drug development services in the fields of developing drug dosage and drug dosage form, drug delivery technologies, drug analytical methods, drug manufacturing research, drug packaging design, drug labeling design, and drug stability evaluations, storage design, and testing
The mark consists of a design comprised of five columns of seven dots of varying sizes. The first column from the left consists of dots in the following colors from top to bottom: red, dark blue, three medium blue, and two light blue. The second column consists of dots in the following colors from top to bottom: red, dark blue, three medium blue, and two light blue. The third column consists of dots in the following colors from top to bottom: red, dark blue, and five medium blue. The fourth column consists of dots in the following colors from top to bottom: red and six dark blue. The last column consists of seven red dots. The color white represents background and/or transparent areas and is not part of the mark.
The color(s) red, dark blue, medium blue and light blue is/are claimed as a feature of the mark.

Trademark Events
Mar 8, 2024
Teas Change Of Correspondence Received
Mar 8, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 8, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 8, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 8, 2024
Teas Change Of Owner Address Received
Feb 28, 2024
Automatic Update Of Assignment Of Ownership
Feb 22, 2024
Notice Of Revival - E-Mailed
Feb 22, 2024
Petition To Revive-Granted
Feb 22, 2024
Teas Petition To Revive Received
Feb 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 12, 2024
Abandonment - No Use Statement Filed
Jun 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2023
Sou Extension 1 Granted
Jun 28, 2023
Sou Extension 1 Filed
Jun 28, 2023
Sou Teas Extension Received
Jan 10, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 7, 2022
Approved For Pub - Principal Register
Oct 7, 2022
Examiner's Amendment Entered
Oct 7, 2022
Notification Of Examiners Amendment E-Mailed
Oct 7, 2022
Examiners Amendment E-Mailed
Oct 7, 2022
Examiners Amendment -Written
Jun 1, 2022
Automatic Update Of Assignment Of Ownership
May 20, 2022
Notification Of Non-Final Action E-Mailed
May 20, 2022
Non-Final Action E-Mailed
May 20, 2022
Non-Final Action Written
May 17, 2022
Assigned To Examiner
Apr 12, 2022
Notice Of Design Search Code E-Mailed
Apr 11, 2022
New Application Office Supplied Data Entered
Apr 8, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24